• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia.

作者信息

Von Wussow P, Hehlmann R, Hochhaus T, Jakschies D, Nolte K U, Prümmer O, Ansari H, Hasford J, Heimpel H, Deicher H

机构信息

Department of Immunology and Transfusion Medicine, Medical School of Hannover, Germany.

出版信息

J Interferon Res. 1994 Aug;14(4):217-9. doi: 10.1089/jir.1994.14.217.

DOI:10.1089/jir.1994.14.217
PMID:7822880
Abstract
摘要

相似文献

1
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia.
J Interferon Res. 1994 Aug;14(4):217-9. doi: 10.1089/jir.1994.14.217.
2
Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha.
Br J Haematol. 1991 Jun;78(2):210-6. doi: 10.1111/j.1365-2141.1991.tb04418.x.
3
A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia.一项关于慢性粒细胞白血病患者采用α-2a干扰素与γ干扰素交替治疗的II期研究。
Cancer. 1991 Nov 15;68(10):2125-30. doi: 10.1002/1097-0142(19911115)68:10<2125::aid-cncr2820681006>3.0.co;2-q.
4
Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.
J Interferon Res. 1989 Sep;9 Suppl 1:S25-31.
5
Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-alpha (rIFN alpha 2a) and neutralizing-rIFN alpha 2a antibodies negative.对重组干扰素-α（rIFNα2a）无反应且中和性rIFNα2a抗体阴性的Ph+慢性髓性白血病患者接受淋巴母细胞样干扰素-α序贯治疗的反应
Haematologica. 1997 May-Jun;82(3):348-50.
6
Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.用天然人干扰素α治疗一名对重组干扰素α-2b有抗体的慢性粒细胞白血病患者。
Blut. 1988 Nov;57(5):311-5. doi: 10.1007/BF00320360.
7
Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study.聚乙二醇化重组干扰素α-2b与重组干扰素α-2b用于慢性期慢性粒细胞白血病初始治疗的III期研究
Leukemia. 2004 Feb;18(2):309-15. doi: 10.1038/sj.leu.2403217.
8
A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Blut. 1989 Jun;58(6):275-8. doi: 10.1007/BF00320165.
9
Therapy of chronic myelogenous leukemia.慢性粒细胞白血病的治疗
Cancer. 1987 Feb 1;59(3 Suppl):664-7. doi: 10.1002/1097-0142(19870201)59:3+<664::aid-cncr2820591316>3.0.co;2-y.
10
Alpha-2a-interferon administration and Fc gamma RIII expression on neutrophils from chronic myeloid leukemia.α-2a干扰素给药与慢性髓性白血病患者中性粒细胞上FcγRIII的表达
Leuk Res. 1996 Jul;20(7):627-8. doi: 10.1016/0145-2126(95)00174-3.

引用本文的文献

1
Immunogenicity of protein therapeutics: The key causes, consequences and challenges.蛋白质治疗药物的免疫原性：关键原因、后果及挑战。
Self Nonself. 2010 Oct;1(4):314-322. doi: 10.4161/self.1.4.13904.
2
Detection of autoantibodies to cytokines.细胞因子自身抗体的检测
Mol Biotechnol. 2000 Mar;14(3):251-61. doi: 10.1385/MB:14:3:251.
3
Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.用于检测α干扰素（IFN-α）制剂中蛋白质聚集体的酶联免疫吸附测定（ELISA）的开发与应用。
Pharm Res. 1997 Oct;14(10):1394-400. doi: 10.1023/a:1012168621337.